Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy
The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Abstract
Voltage-gated sodium channels (Na(V)) are critical for initiation of action potentials. Heterozygous loss-of-function mutations in Na(V)1.1 channels cause severe myoclonic epilepsy in infancy (SMEI). Homozygous null Scn1a-/- mice developed ataxia and died on postnatal day (P) 15 but could be sustained to P17.5 with manual feeding. Heterozygous Scn1a+/- mice had spontaneous seizures and sporadic deaths beginning after P21, with a notable dependence on genetic background. Loss of Na(V)1.1 did not change voltage-dependent activation or inactivation of sodium channels in hippocampal neurons. The sodium current density was, however, substantially reduced in inhibitory interneurons of Scn1a+/- and Scn1a-/- mice but not in their excitatory pyramidal neurons. An immunocytochemical survey also showed a specific upregulation of Na(V)1.3 channels in a subset of hippocampal interneurons. Our results indicate that reduced sodium currents in GABAergic inhibitory interneurons in Scn1a+/- heterozygotes may cause the hyperexcitability that leads to epilepsy in patients with SMEI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, a dominant loss of function mutation in Nav1.1 causes Dravet syndrome, an intractable form of childhood-onset epilepsy that arises from a reduction in Na+ channel density in hippocampal interneurons (1255).”
From Hippocampal GABAergic Inhibitory Interneurons (2017) · cites this paper as [1255]
In the citing paper
“Haploinsufficiency or pathogenic variants of Scn1a cause Dravet Syndrome, a common and intractable form of epileptic encephalopathy characterized by the early onset of seizures17–19.”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [19]
In the citing paper
“As loss of expression of Scn1a is especially associated with PV cIN disfunction15–19”
From Viral manipulation of functionally distinct interneurons in mice, non-human primates and humans (2020) · cites this paper as [19]
Citations
Cites
Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.
Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., & Roder, J. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8424 · Cited by 2,329 · cited 1×
“The targeting construct was linearized at the Not I site in the polylinker and was electroporated into R1 embryonic stem cell”
MethodEngel, J. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.10401.x · Cited by 2,251
From Ionic Currents to Molecular Mechanisms
Catterall, W. A. (2000) · Neuron · doi:10.1016/s0896-6273(00)81133-2 · Cited by 2,118 · cited 1×
“dtd" [ ]> Voltage-gated Na + channels in the brain are complexes of a 260-kDa α-subunit in association with auxiliary β-subunits (β1–β4) of 33 to 36 kD”
Self-citationEpileptic Syndromes in Infancy, Childhood and Adolescence
Rogers, J., Bureau, M., Dravet, C., Dreifuss, F. E., Perret, A., Wolf, P., & Armstrong, D. L. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199307000-00012 · Cited by 1,470
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292
(2005) · Cited by 944
Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy
de Lanerolle, N. C., Kim, J. H., Robbins, R. J., & Spencer, D. D. (1989) · Brain Research · doi:10.1016/0006-8993(89)90234-5 · Cited by 927
Buhl, E. H., Halasy, K., & Somogyi, P. (1994) · Nature · doi:10.1038/368823a0 · Cited by 728
Overview of the voltage-gated sodium channel family
Yu (2003) · Genome biology · doi:10.1186/gb-2003-4-3-207 · Cited by 694 · cited 1×
“dtd" [ ]> Voltage-gated Na + channels in the brain are complexes of a 260-kDa α-subunit in association with auxiliary β-subunits (β1–β4) of 33 to 36 kD”
Sodium channel Na v 1.6 is localized at nodes of Ranvier, dendrites, and synapses
Caldwell, J. H., Schaller, K. L., Lasher, R. S., Peles, E., & Levinson, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090034797 · Cited by 649 · cited 1×
“6 is localized in dendrites and in the nodes of Ranvie”
Background
Cited by
Items 201–300 of 1,000
Reduced Sodium Channel Nav1.1 Levels in BACE1-null Mice
Kim, D. Y., Gersbacher, M. T., Inquimbert, P., & Kovacs, D. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134692 · Cited by 85
Current understanding and neurobiology of epileptic encephalopathies
Auvin, S., Cilio, M. R., & Vezzani, A. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.03.007 · Cited by 89
“An impairment of GABAergic firing has been observed in hippocampal interneurons, resulting in seizure susceptibility in cerebellar Purkinje cells, explaining motor symptoms such as ataxia (Yu et al., 2006; Ogiwara et al., 2007).”
Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome
Schoonjans, A., Lagae, L. G., & Ceulemans, B. (2015) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285615607726 · Cited by 83
The pharmacology of voltage-gated sodium channel activators
Deuis, J. R., Mueller, A., Israel, M. R., & Vetter, I. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.014 · Cited by 89
Pathophysiological mechanisms of migraine and epilepsy: Similarities and differences
Mantegazza, M., & Cestèle, S. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.11.025 · Cited by 86
Self-citationAngelman Syndrome: From Mouse Models to Therapy
Rotaru, D. C., Mientjes, E., & Elgersma, Y. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.02.017 · Cited by 85
Sakauchi, M., Oguni, H., Kato, I., Osawa, M., Hirose, S., Kaneko, S., Takahashi, Y., Takayama, R., & Fujiwara, T. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03053.x · Cited by 80
“The epileptic seizures associated with Dravet syndrome are presumably generated by epileptogenic pyramidal neurons because of an SCN1A mutation–mediated dysfunction of inhibitory interneurons (Yu et al., 2006; Ogiwara et al., 2007).”
BackgroundJohnson, J., Focken, T., Khakh, K., Tari, P. K., Dube, C., Williams, A., Andrez, J.-C., Bankar, G., Bogucki, D., Burford, K., et al. (2022) · eLife · doi:10.7554/elife.72468 · Cited by 85
“…the predominance of Na V 1.1 in inhibitory inter-neurons ( Catterall et al., 2010 ; Claes et al., 2001 ; Escayg et al., 2000 ; Mistry et al., 2014 ; Yu et al., 2006 ), while the opposite is true for Na V 1.2 and Na V 1.6 currents ( Ben-Shalom et al., 2017 ; Hawkins et al., 2011 ; Martin et al.,…”
InfluentialIssues related to development of new antiseizure treatments
Wilcox, K. S., Dixon‐Salazar, T., Sills, G. J., Ben‐Menachem, E., Steve White, H., Porter, R. J., Dichter, M. A., Moshé, S. L., Noebels, J. L., Privitera, M. D., et al. (2013) · Epilepsia · doi:10.1111/epi.12296 · Cited by 79
“However, few of these models have been characterized in terms of their responsiveness to existing ASDs (Yu et al., 2006; Oakley et al., 2013; Zhang et al., 2013).”
BackgroundVoltage-gated sodium channel β subunits: The power outside the pore in brain development and disease
Hull, J. M., & Isom, L. L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.018 · Cited by 93
Understanding Spreading Depression from Headache to Sudden Unexpected Death
Cozzolino, O., Marchese, M., Trovato, F., Pracucci, E., Ratto, G. M., Buzzi, M. G., Sicca, F., & Santorelli, F. M. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00019 · Cited by 86
Ricobaraza, A., Mora-Jimenez, L., Puerta, E., Sánchez-Carpintero, R., Mingorance, A., Artieda, J., Nicolás, M. J., Besné, G. M., Buñuales, M., González-Aparicio, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50627-w · Cited by 92
Valassina, N., Brusco, S., Salamone, A., Serra, L., Luoni, M., Giannelli, S. G., Bido, S., Massimino, L., Ungaro, F., Mazzara, P. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27837-w · Cited by 85
Teper, Y., Whyte, D., Cahir, E., Lester, H. A., Grady, S. R., Marks, M. J., Cohen, B. N., Fonck, C., McClure-Begley, T., McIntosh, J. M., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3042-07.2007 · Cited by 77
“The mice showed a dramatically different phenotype depending on genetic background: frequent spontaneous seizures in a C57BL/6 background and no seizures in a 129/SvJ background (Yu et al., 2006).”
BackgroundUnexpected Efficacy of a Novel Sodium Channel Modulator in Dravet Syndrome
Anderson, L. L., Hawkins, N. A., Thompson, C. H., Kearney, J. A., & George, A. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-01851-9 · Cited by 76
SCN8A encephalopathy: Mechanisms and models
Meisler, M. H. (2019) · Epilepsia · doi:10.1111/epi.14703 · Cited by 77
Do seizures and epileptic activity worsen epilepsy and deteriorate cognitive function?
Avanzini, G., Depaulis, A., Tassinari, A., & de Curtis, M. (2013) · Epilepsia · doi:10.1111/epi.12418 · Cited by 78
“1 identified in DS patients (Yu et al., 2006).”
Severe myoclonic epilepsy in infancy (Dravet syndrome) 30 years later
Dravet, C., Bureau, M., Bernardina, B. D., & Guerrini, R. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.02993.x · Cited by 78
“2):1–2, 2011 doi: 10.1111/j.1528-1167.2011.02993.x DRAVET SYNDROME 1 epileptogenesis (Yu et al., 2006; Ogiwara et al., 2007; Oakley et al., 2009).”
InfluentialPhysiological bases of the K+ and the glutamate/GABA hypotheses of epilepsy
DiNuzzo, M., Mangia, S., Maraviglia, B., & Giove, F. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.04.001 · Cited by 76
Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome
Liautard, C., Scalmani, P., Carriero, G., de Curtis, M., Franceschetti, S., & Mantegazza, M. (2013) · Epilepsia · doi:10.1111/epi.12213 · Cited by 76
“1 +/ neuronal networks (Yu et al., 2006; Ogiwara et al., 2007; Han et al., 2012), but with a more prominent reduction in the epileptic period, and that standard 4-AP ictal-like discharges may not be a specific ictal-like activity of NaV1.”
BackgroundSelf-citationLöscher, W., Ferland, R. J., & Ferraro, T. N. (2017) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2017.05.040 · Cited by 85
Dendritic ion channelopathy in acquired epilepsy
Poolos, N. P., & Johnston, D. (2012) · Epilepsia · doi:10.1111/epi.12033 · Cited by 75
“1, mimicking mutations seen in SMEI, show no significant alteration in INa, whereas hippocampal interneurons have a substantial loss of INa and decreased repetitive firing in response to stimulation (Yu et al., 2006).”
Advances in Targeting Voltage‐Gated Sodium Channels with Small Molecules
Nardi, A. E., Damann, N., Hertrampf, T., & Kless, A. (2012) · ChemMedChem · doi:10.1002/cmdc.201200298 · Cited by 77
Translational Research in Epilepsy Genetics: Sodium Channels in Man to Interneuronopathy in Mouse
Mullen, S. A., & Scheffer, I. E. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.559 · Cited by 76
Precision medicine in genetic epilepsies: break of dawn?
Reif, P. S., Tsai, M., Helbig, I., Rosenow, F., & Klein, K. M. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2017.1253476 · Cited by 79
Rotaru, D. C., van Woerden, G. M., Wallaard, I., & Elgersma, Y. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.0083-18.2018 · Cited by 74
“1 subtype may lead to lower excitability of FS interneurons in AS mice (Yu et al., 2006; Ogiwara et al., 2007; von Schoubye et al., 2018).”
BackgroundNew insights into the early mechanisms of epileptogenesis in a zebrafish model of Dravet syndrome
Tiraboschi, E., Martina, S., van der Ent, W., Grzyb, K., Gaweł, K., Cordero-Maldonado, M. L., Poovathingal, S. K., Heintz, S., Satheesh, S. V., Brattespe, J., et al. (2020) · Epilepsia · doi:10.1111/epi.16456 · Cited by 82
Voltage-Gated Sodium Channels: Structure, Function, and Pathophysiology
Catterall, W. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-378630-2.00208-5 · Cited by 75
Self-citationModelling epilepsy in the mouse: challenges and solutions
Marshall, G. F., Gonzalez‐Sulser, A., & Abbott, C. M. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.047449 · Cited by 88
Ciccone, R., Franco, C., Piccialli, I., Boscia, F., Casamassa, A., de Rosa, V., Cepparulo, P., Cataldi, M., Annunziato, L., & Pannaccione, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-50018-1 · Cited by 74
Kaneko, K., Currin, C. B., Goff, K. M., Wengert, E. R., Somarowthu, A., Vogels, T. P., & Goldberg, E. M. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110580 · Cited by 72
“…demonstrated that abnormalities in PV-IN spike generation in Scn1a +/− mice were in fact transient and restricted to early developmental time points (Yu et al., 2006; Ogiwara et al., 2007; Tai et al., 2014; Tsai et al., 2015; De Stasi et al., 2016); PV-INs in young-adult Scn1a +/− P35–P56 mice had…”
Hyperexcitable interneurons trigger cortical spreading depression in an Scn1a migraine model
Auffenberg, E., Hedrich, U. B. S., Barbieri, R., Miely, D., Groschup, B., Wuttke, T. V., Vogel, N., Lührs, P., Zanardi, I., Bertelli, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142202 · Cited by 75
“1 expression in the second and third postnatal week (15, 16, 48).”
BackgroundHawkins, N. A., Zachwieja, N. J., Miller, A. R., Anderson, L. L., & Kearney, J. A. (2016) · PLOS Genetics · doi:10.1371/journal.pgen.1006398 · Cited by 71
Recent advances in gene therapy for neurodevelopmental disorders with epilepsy
Turner, T. J., Zourray, C., Schorge, S., & Lignani, G. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15168 · Cited by 71
“AAV delivery of Fmr1 ameliorates the hippocampal dysfunction and behavioural phenotypes of Fmr1-KO mice (Gholizadeh et al. 2014; Zeier et al. 2009).”
BackgroundBrackenbury, W. J., Yuan, Y., O’Malley, H. A., Parent, J. M., & Isom, L. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208767110 · Cited by 77
“Haploinsufficiency of Scn1a in hippocampal inhibitory interneurons is proposed to be a causative factor in DS, by reducing negative feedback regulation of hippocampal circuitry (25, 26).”
BackgroundGenetics of reflex seizures and epilepsies in humans and animals
Italiano, D., Striano, P., Russo, E., Leo, A., Spina, E., Zara, F., Striano, S., Gambardella, A., Labate, A., Gasparini, S., et al. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.01.010 · Cited by 73
Molecular genetics of Dravet syndrome
Jonghe, P. D. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2011.03965.x · Cited by 75
SCN3A deficiency associated with increased seizure susceptibility
Lamar, T., Vanoye, C. G., Calhoun, J., Wong, J. C., Dutton, S. B. B., Jorge, B. S., Velinov, M., Escayg, A., & Kearney, J. A. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.006 · Cited by 70
Mantegazza, M., & Broccoli, V. (2019) · Epilepsia · doi:10.1111/epi.14700 · Cited by 71
Self-citationA Common Susceptibility Factor of Both Autism and Epilepsy: Functional Deficiency of GABAA Receptors
Kang, J., & Barnes, G. N. (2012) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-012-1543-7 · Cited by 77
Westenbroek, R. E., Bischoff, S., Fu, Y., Maier, S. K. G., Catterall, W. A., & Scheuer, T. (2013) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.08.004 · Cited by 78
“1 knockout mice [16, 17] to demonstrate specificity of the antibody via western blot and immunocytochemistry.”
Self-citationFirst FHM3 mouse model shows spontaneous cortical spreading depolarizations
Jansen, N. A., Dehghani, A., Linssen, M. M. L., Breukel, C., Tolner, E. A., & van den Maagdenberg, A. M. J. M. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50971 · Cited by 72
Epileptogenic Channelopathies: Experimental Models of Human Pathologies
AVANZINI, G., Franceschetti, S., & Mantegazza, M. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01067.x · Cited by 75
“…might help to clarify this point, but encouraging results have been obtained from the evaluation of heterozygous SCN1A knockout mice presenting with severe seizures, probably caused by decreased excitability of GABAergic neurons, and with a very high, postnatal mortality rate (Yu et al., 2006).”
ResultSelf-citationAnderson, L. L., Heblinski, M., Absalom, N. L., Hawkins, N. A., Bowen, M. T., Benson, M. J., Zhang, F., Bahceci, D., Doohan, P. T., Chebib, M., et al. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15661 · Cited by 74
“…and even between cohorts within the same laboratory under identical experimental conditions (Anderson, Absalom, et al., 2019; Anderson et al., 2020; Benson et al., 2020; Han et al., 2020; Hawkins et al., 2017; Miller et al., 2014; Mistry et al., 2014; Patra et al., 2020; Yu et al., 2006).”
BackgroundEpilepsy and outcome in FOXG1‐related disorders
Seltzer, L. E., Ma, M., Ahmed, S., Bertrand, M. E., Dobyns, W. B., Wheless, J. W., & Paciorkowski, A. R. (2014) · Epilepsia · doi:10.1111/epi.12648 · Cited by 69
Insights into pathophysiology and therapy from a mouse model of Dravet syndrome
Oakley, J. C., Kalume, F., & Catterall, W. A. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03004.x · Cited by 68
“This reduction in sodium current caused a loss of sustained high-frequency firing of action potentials in hippocampal and cortical interneurons (Yu et al., 2006; Ogiwara et al., 2007), thereby impairing their in vivo inhibitory function that depends on generation of high-frequency bursts of action…”
BackgroundMethodSelf-citationTau-induced pathology in epilepsy and dementia: notions from patients and animal models.
Sánchez, M., García-Cabrero, A., Sánchez-Elexpuru, G., Burgos, D., & Serratosa, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041092 · Cited by 68
Oxidative Stress, a Crossroad Between Rare Diseases and Neurodegeneration
Espinós, C., Galindo, M. I., García-Gimeno, M. A., Ibáñez-Cabellos, J. S., Martínez‐Rubio, D., Millán, J. M., Rodrigo, R., Sanz, P., Seco-Cervera, M., Sevilla, T., et al. (2020) · Antioxidants · doi:10.3390/antiox9040313 · Cited by 73
Divergent effects of the T 1174S SCN1A mutation associated with seizures and hemiplegic migraine
Cestèle, S., Labate, A., Rusconi, R., Tarantino, P., Mumoli, L., Franceschetti, S., Annesi, G., Mantegazza, M., & Gambardella, A. (2013) · Epilepsia · doi:10.1111/epi.12123 · Cited by 77
“1 induces a decrease of Na + current in c-aminobutyric acid (GABA)ergic interneurons and reduction of their excitability in gene targeted mice (Yu et al., 2006; Ogiwara et al., 2007; Martin et al., 2010).”
BackgroundSelf-citationMonogenic models of absence epilepsy
Maheshwari, A., & Noebels, J. L. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00012-0 · Cited by 74
Stein, R. E., Kaplan, J. S., Li, J., & Catterall, W. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1906833116 · Cited by 74
Self-citationPure haploinsufficiency for Dravet syndrome NaV1.1 (SCN1A) sodium channel truncating mutations
Bechi, G., Scalmani, P., Schiavon, E., Rusconi, R., Franceschetti, S., & Mantegazza, M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03346.x · Cited by 67
“1 mutant (Yu et al., 2006).”
BackgroundMethodResultSelf-citationDe Stasi, A. M., Farisello, P., Marcon, I., Cavallari, S., Forli, A., Vecchia, D., Losi, G., Mantegazza, M., Panzeri, S., Carmignoto, G., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw002 · Cited by 70
“Remarkably, however, both in cortical structures and in cerebellum, GABAergic inhibitory interneurons exhibited a significant decrease in voltagedependent sodium current, leading to reduced firing (Yu et al. 2006).”
BackgroundMethodResultSelf-citationDisordered breathing in a mouse model of Dravet syndrome
Kuo, F., Cleary, C. M., LoTurco, J. J., Chen, X., & Mulkey, D. K. (2019) · eLife · doi:10.7554/elife.43387 · Cited by 78
Interneuron Transplantation as a Treatment for Epilepsy
Hunt, R. F., & Baraban, S. C. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022376 · Cited by 70
Qiao, X., Sun, G., Clare, J. J., Werkman, T. R., & Wadman, W. J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12534 · Cited by 79
“1 subunit (than to the other three subtypes), the predominant Na+ channel subtype in certain subpopulations of inhibitory interneurons (Yu et al., 2006; Ogiwara et al., 2007; Lorincz and Nusser, 2008).”
BackgroundInfluentialRusconi, R., Combi, R., Cestèle, S., Grioni, D., Franceschetti, S., Dalprà, L., & Mantegazza, M. (2009) · Human Mutation · doi:10.1002/humu.21041 · Cited by 67
“Thus, early diagnosis of phenotype severity in GEFS+ families and suspected SMEI cases might be improved by genetic analysis of Na + channel interacting proteins.”
BackgroundInfluentialSelf-citationMashimo, T., Ohmori, I., Ouchida, M., Ohno, Y., Tsurumi, T., Miki, T., Wakamori, M., Ishihara, S., Yoshida, T., Takizawa, A., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3360-09.2010 · Cited by 73
“1 channel gene SCN1A have been reported in 200 cases, ranging in severity from the comparatively mild disorder of generalized epilepsy with febrile seizures plus (GEFS ) to the epileptic encephalopathy of severe myoclonic epilepsy in infancy (SMEI).”
BackgroundMethodInfluentialVoltage-Gated Sodium Channel Dysfunctions in Neurological Disorders
Barbieri, R., Nizzari, M., Zanardi, I., Pusch, M., & Gavazzo, P. (2023) · Life · doi:10.3390/life13051191 · Cited by 75
Galanopoulou, A., & Moshé, S. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.015 · Cited by 63
Guet-McCreight, A., Skinner, F. K., & Topolnik, L. (2020) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.00032 · Cited by 67
Channelopathy as a SUDEP Biomarker in Dravet Syndrome Patient-Derived Cardiac Myocytes
Frasier, C. R., Zhang, H., Offord, J., Dang, L. T., Auerbach, D. S., Shi, H., Chen, C., Goldman, A. M., Eckhardt, L. L., Bezzerides, V. J., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.07.012 · Cited by 69
“This work demonstrated that, in addition to aberrant central and peripheral neuronal excitability (Kalume et al., 2013; Yu et al., 2006), DS mice have differences in CM ionic currents that serve as substrates for arrhythmias.”
BackgroundFGF14 localization and organization of the axon initial segment
Xiao, M., Bosch, M. K., Nerbonne, J. M., & Ornitz, D. M. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2013.07.008 · Cited by 67
Dual roles of voltage-gated sodium channels in development and cancer
Patel, F., & Brackenbury, W. J. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150171wb · Cited by 70
Cortical interneuron dysfunction in epilepsy associated with autism spectrum disorders
Jacob, J. (2016) · Epilepsia · doi:10.1111/epi.13272 · Cited by 63
Pereira, A. R. S., Duprat, F., Pousinha, P. A., Loucif, A., Douchamps, V., Regondi, M. C., Ayrault, M., Eugie, M., Stunault, M. I., Escayg, A., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.006 · Cited by 65
Self-citationMartin, P., Reeder, T., Sourbron, J., de Witte, P. A. M., Gammaitoni, A. R., & Galer, B. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168416 · Cited by 57
Deletions of SCN1A 5′ genomic region with promoter activity in Dravet syndrome
Nakayama, T., Ogiwara, I., Ito, K., Kaneda, M., Mazaki, E., Osaka, H., Ohtani, H., Inoue, Y., Fujiwara, T., Uematsu, M., et al. (2010) · Human Mutation · doi:10.1002/humu.21275 · Cited by 62
“The mice heterozygous for an Scn1a null allele, and heterozygotes for an Scn1a truncation mutation, exhibited severe seizure phenotypes [Ogiwara et al., 2007; Yu et al., 2006].”
BackgroundSpoleti, E., Barbera, L. L., Cauzzi, E., Paolis, M. L. D., Saba, L., Marino, R., Sciamanna, G., Lazzaro, V. D., Keller, F., Nobili, A., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02408-9 · Cited by 66
“3B), proving an age-dependent and progressive loss of PV-INs that we detected between 1-and 3-months.”
BackgroundMich, J. K., Ryu, J., Wei, A. D., Gore, B. B., Guo, R., Bard, A. M., Martinez, R. A., Luber, E. M., Liu, J., Bishaw, Y. M., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adn5603 · Cited by 69
Self-citationVolkers, L., Kahlig, K. M., Verbeek, N. E., Das, J. H. G., van Kempen, M. J. A., Stroink, H., Augustijn, P., van Nieuwenhuizen, O., Lindhout, D., George, A. L., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07826.x · Cited by 60
“…studies, but this finding is concordant with the general loss-of-function hypothesis of DS and supported by Scn1a+ ⁄ ) mice, which show that a reduction in sodium current in GABAergic inhibitory interneurons is sufficient to cause DS (Yu et al., 2006; Ogiwara et al., 2007; Catterall et al., 2010).”
InfluentialModulation of neuronal sodium channels by the sea anemone peptide BDS-I
Pin, L., Jo, S., & Bean, B. P. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00785.2011 · Cited by 61
Papale, L. A., Makinson, C. D., Ehlen, J. C., Tufik, S., Decker, M. J., Paul, K. N., & Escayg, A. (2013) · Epilepsia · doi:10.1111/epi.12060 · Cited by 68
Hawkins, N. A., Jurado, M., Thaxton, T. T., Duarte, S., Barse, L. W., Tatsukawa, T., Yamakawa, K., Nishi, T., Kondo, S., Miyamoto, M., et al. (2021) · Epilepsia · doi:10.1111/epi.17062 · Cited by 61
Genetic therapeutic advancements for Dravet Syndrome
Chilcott, E. M., Diaz, J. F. A., Bertram, C., Berti, M., & Karda, R. (2022) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2022.108741 · Cited by 62
“where the authors established a Scn1a / mouse model which developed spontaneous seizures, ataxia, and died by postnatal day 15 (P15) [41].”
BackgroundInfluentialCossart, R. (2010) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2010.10.003 · Cited by 69
Sudden unexpected death in Dravet syndrome: Respiratory and other physiological dysfunctions
Kalume, F. (2013) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2013.06.026 · Cited by 62
Self-citationXu, J., & Tang, F.-R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092735 · Cited by 64
SCN1A variants from bench to bedside—improved clinical prediction from functional characterization
Brunklaus, A., Schorge, S., Smith, A. D., Ghanty, I., Stewart, K., Gardiner, S., Du, J., Pérez‐Palma, E., Symonds, J. D., Collier, A. C., et al. (2020) · Human Mutation · doi:10.1002/humu.23943 · Cited by 63
A review of the genetic relation between migraine and epilepsy.
Haan, J., Terwindt, G. M., van den Maagdenberg, A. M. J. M., Stam, A., & Ferrari, M. D. (2008) · PubMed · doi:10.1111/j.1468-2982.2007.01460.x · Cited by 60
SCN1A -deficient excitatory neuronal networks display mutation-specific phenotypes
van Hugte, E., Lewerissa, E., Wu, K. M., Scheefhals, N., Parodi, G., van Voorst, T. W., Puvogel, S., Kogo, N., Keller, J. M., Frega, M., et al. (2023) · Brain · doi:10.1093/brain/awad245 · Cited by 64
“13 However, our data also point to a compensatory mechanism from K v -channels.”
Ohmori, I., Ouchida, M., Miki, T., Mimaki, N., Kiyonaka, S., Nishiki, T., Tomizawa, K., Mori, Y., & Matsui, H. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.07.017 · Cited by 60
“Third, the severity of epilepsy in a mouse model of SMEI harboring a truncated SCN1A mutation was influenced by the genetic background (Yu et al., 2006; Ogiwara et al., 2007).”
Knock-in model of Dravet syndrome reveals a constitutive and conditional reduction in sodium current
Schutte, R. J., Schutte, S. S., Algara, J., Barragan, E. V., Gilligan, J., Staber, C., Savva, Y. A., Smith, M. A., Reenan, R., & O'Dowd, D. K. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00135.2014 · Cited by 59
“Studies in a mouse SCN1A knock-out and a SCN1A DS nonsense mutation knock-in (R1407X) report sodium currents with reduced magnitude and reduced excitability in inhibitory neurons at behaviorally permissive temperatures (Ogiwara et al. 2007; Yu et al. 2006).”
BackgroundCacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome
Calhoun, J. D., Hawkins, N. A., Zachwieja, N. J., & Kearney, J. A. (2017) · Epilepsia · doi:10.1111/epi.13811 · Cited by 58
Epileptogenic ion channel mutations: From bedside to bench and, hopefully, back again
Mantegazza, M., Rusconi, R., Scalmani, P., AVANZINI, G., & Franceschetti, S. (2010) · Epilepsy Research · doi:10.1016/j.eplepsyres.2010.08.003 · Cited by 61
Self-citationGuerrini, R., Marini, C., & Mantegazza, M. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0267-0 · Cited by 63
“These findings suggest that Dravet syndrome, and probably the other SCN1A-related seizure disorders, are caused by a decreased excitability of GABAergic interneurons owing to SCN1A haploinsufficiency [25, 26].”
BackgroundSelf-citationAugmented Reticular Thalamic Bursting and Seizures in Scn1a-Dravet Syndrome
Makinson, S. R., Clemente-Perez, A., Higashikubo, B. T., Cho, F. S., Holden, S. S., Bennett, E., Chkhaidze, A., Rooda, O. H. J. E., Cornet, M., Hoebeek, F. E., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.018 · Cited by 61
“…that sodium channel deficits in GABAergic neurons result in reduced firing, leading to the hypothesis that reduced network inhibition in the neocortex and hippocampus promotes convulsive seizures (Cheah et al., 2012; Dutton et al., 2013; Ogiwara et al., 2007; Tai et al., 2014; Yu et al., 2006).”
BackgroundInfluentialGuo, F., Yu, N., Cai, J.-Q., Quinn, T., Zong, Z., Zeng, Y., & Hao, L. (2007) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2007.10.005 · Cited by 63
Synergistic GABA-Enhancing Therapy against Seizures in a Mouse Model of Dravet Syndrome
Oakley, J. C., Cho, A. R., Cheah, C. S., Scheuer, T., & Catterall, W. A. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203331 · Cited by 56
Self-citationPharmacokinetic, Pharmacodynamic, and Pharmacogenetic Targeted Therapy of Antiepileptic Drugs
Anderson, G. D. (2008) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e318167d11b · Cited by 64
“Topiramate and stiripentol are the most effective AEDs in the treatment of SMEI.”
BackgroundInfluentialAdvances in Epilepsy: Mechanisms, Clinical Trials, and Drug Therapies
Hu, T., Zhang, J., Wang, J., Sha, L., Xia, Y., Ortyl, T. C., Tian, X., & Chen, L. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01975 · Cited by 59
Protective effect of the ketogenic diet in Scn1a mutant mice
Dutton, S. B. B., Sawyer, N. T., Kalume, F. K., Jumbo‐Lucioni, P. P., Borges, K., Catterall, W. A., & Escayg, A. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03211.x · Cited by 57
“Animals Heterozygous Scn1a knockout mice (Scn1a, a model of DS) and heterozygous knock-in mice with the human SCN1A GEFS+ mutation R1648H (Scn1a, a model of GEFS+) were generated as described previously (Yu et al., 2006; Martin et al., 2010).”
BackgroundMethodInfluentialSelf-citationTsai, M.-S., Lee, M.-L., Chang, C.-Y., Fan, H.-H., Yu, I.-S., Chen, Y.-T., You, J.-Y., Chen, C.-Y., Chang, F.-C., Hsiao, J. H., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.010 · Cited by 55
“This idea is supported by the observation that variousmutations (nonsense and deletion) in Scn1a result in reduced Na+ current in inhibitory neurons (Mistry et al., 2014; Ogiwara et al., 2007; Tai et al., 2014; Yu et al., 2006).”
InfluentialCurrent therapeutic procedures in Dravet syndrome
CHIRON, C. (2011) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2011.03967.x · Cited by 55
Gene expression profiling in a mouse model of Dravet syndrome
Hawkins, N. A., Calhoun, J. D., Huffman, A. M., & Kearney, J. A. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.10.010 · Cited by 58
“A common feature of epilepsy mouse models, including the Scn1a+/− Dravet model, is strain-dependent differences in phenotype severity (Bergren et al., 2005; Miller et al., 2014; Ogiwara et al., 2007; Yu et al., 2006).”
InfluentialChever, O., Zerimech, S., Scalmani, P., Lemaire, L., Pizzamiglio, L., Loucif, A., Ayrault, M., Крупа, М. М., Desroches, M., Duprat, F., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142203 · Cited by 56
“1 does not in general modify firing properties of these neurons (6-11).”
BackgroundSelf-citationMenzler, K., Hermsen, A., Balkenhol, K., Duddek, C., Bugiel, H., Bauer, S., Schorge, S., Reif, P. S., Klein, K. M., Haag, A., et al. (2014) · Epilepsia · doi:10.1111/epi.12515 · Cited by 59
“However, in mouse models a mutation (R1648H) or knockout of SCN1A alters electrophysiologic properties and reduces sodium channel function in GABAergic interneurons, but not excitatory pyramidal cells.(1,31,32) This is likely due to the differential expression of the sodium channel Nav1.”
BackgroundYuan, Y., Lopez‐Santiago, L. F., Denomme, N., Chen, C., O’Malley, H. A., Hodges, S. L., Ji, S., Zhou, H., Christiansen, A., & Isom, L. L. (2023) · Brain · doi:10.1093/brain/awad349 · Cited by 56
Ye, M., Yang, J., Tian, C., Zhu, Q., Yin, L., Jiang, S., Yang, M., & Shu, Y. (2018) · Scientific Reports · doi:10.1038/s41598-017-17344-8 · Cited by 63
“The integrated seizure score for Scn8a−/− mice over the entire course was 13% and 20% higher than that for Scn8a+/− and Scn8a+/+ mice respectively (F(2,21) = 10.”
BackgroundResolving the Micro-Macro Disconnect to Address Core Features of Seizure Networks
Farrell, J. S., Nguyen, Q.-A., & Soltész, I. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.043 · Cited by 57
Metadata
- Authors
- Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A.
- Affiliations
- University of Washington (US)
- Corresponding author
- Catterall, William A
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-08-20
- Volume
- 9
- Issue
- 9
- Pages
- 1142-1149
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2105423985
- Cited by
- 1,173
- References
- 55
- Citations by year
- 2026: 54 · 2025: 72 · 2024: 66 · 2023: 69 · 2022: 73 · 2021: 85 · 2020: 70 · 2019: 70 · 2018: 53 · 2017: 59 · 2016: 47 · 2015: 63 · 2014: 64 · 2013: 64 · 2012: 52
- FWCI
- 22.30
- Type
- journal article
- Language
- en
- Update notices
- erratum (2007-01-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- Dravet syndrome, SCN1A, Nav1.3, GABAergic interneurons, sodium current, hippocampus, neuronal hyperexcitability, epilepsy, genetic background effects
- MeSH terms
- Action Potentials, Animals, Cell Line, Disease Models, Animal, Electroencephalography, Epilepsies, Myoclonic, gamma-Aminobutyric Acid, Genotype, Humans, Infant, Interneurons, Mice, Inbred C57BL, Mice, Inbred Strains, Mutation, Nerve Tissue Proteins, Phenotype, Seizures, Immunoblotting, Sodium Channels, Survival Rate, Mice, Knockout, Patch-Clamp Techniques, Mice, NAV1.1 Voltage-Gated Sodium Channel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.